Back
Stryker Corporation (SYK)
Health CareSYK · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$329.31
+0.48%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$8.40
ROE
15.2%
Gross margin
64.7%
Debt/Equity
0.66x
Revenue growth
2.6%
Stryker Corporation — company intelligence
Earnings surprises
Q2 2026$3.69 vs $3.52 est+4.7%
Q1 2026$2.60 vs $3.01 est-13.7%
Q4 2025$4.47 vs $4.44 est+0.7%
Q3 2025$3.19 vs $3.16 est+0.8%
Analyst consensus · 34 analysts
28 Buy6 Hold0 Sell
Updated Aug 18, 2026
Insider activity · 90 days
0 buys10 sellsnet -5,437 shares
Fletcher Robert SSell 94 · Aug 1, 2026
Fink M KathrynSell 111 · Aug 1, 2026
Montagnino Kimberly AnnSell 155 · Aug 1, 2026
Recent SEC filings
4 — Insider transaction reportAug 20, 2026
4 — Insider transaction reportAug 18, 2026
4 — Insider transaction reportAug 4, 2026
Latest news
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land — SeekingAlpha · 5d ago
Disappointing Ortho Performance Continues To Hold Smith & Nephew Back (Downgrade) — SeekingAlpha · 6d ago
A Congress Member Bought Up To $60K In Amazon.com Stock: Here's What You Need To Know — Benzinga · 6d ago
Stryker Corporation: Hold For Quality, Wait For The Dip — SeekingAlpha · 1w ago
Stryker (NYSE:SYK): A Quality Investment for Long-Term Investors — ChartMill · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.